Nevada
|
90-0273142
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
500 Union Street, Suite 420, Seattle, Washington USA
|
98101
|
(Address of principal executive offices)
|
(Zip Code)
|
206-903-1351
|
||
(Registrant's telephone number, including area code)
|
||
N/A
|
||
(Former name, address, and fiscal year, if changed since last report)
|
TABLE OF CONTENTS
|
||
Page Number
|
||
PART I
|
FINANCIAL INFORMATION
|
3 |
ITEM 1
|
Financial Statements (unaudited except as noted)
|
3 |
Consolidated Balance Sheets as of June 30, 2013 and September 30, 2012 (audited)
|
3 | |
Consolidated Statements of Operations for the three and nine months ended June 30, 2013 and 2012
|
4 | |
Consolidated Statements of Cash Flows for the nine months ended June 30, 2013 and 2012
|
5 | |
Notes to the Financial Statements
|
6 | |
ITEM 2
|
Management's Discussion and Analysis of Financial Condition and Results of Operation
|
18 |
ITEM 3
|
Quantitative and Qualitative Disclosures About Market Risk
|
25 |
ITEM 4
|
Controls and Procedures
|
25 |
PART II
|
OTHER INFORMATION
|
26 |
ITEM 1A.
|
Risk Factors
|
26 |
ITEM 2
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
30 |
ITEM 5
|
Other Information
|
31 |
ITEM 6
|
Exhibits and Reports on Form 8-K
|
31 |
SIGNATURES
|
32 |
ITEM 1.
|
FINANCIAL STATEMENTS
|
VISUALANT, INC. AND SUBSIDIARIES
|
||||||||
CONSOLIDATED BALANCE SHEETS
|
||||||||
June 30, 2013
|
September 30, 2012
|
|||||||
ASSETS
|
(Audited)
|
|||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
$ | 1,509,829 | $ | 1,141,165 | ||||
Restricted cash
|
200,000 | - | ||||||
Accounts receivable, net of allowance of $40,750 and $16,750, respectively
|
809,856 | 1,012,697 | ||||||
Prepaid expenses
|
63,463 | 222,978 | ||||||
Inventories
|
690,629 | 344,692 | ||||||
Refundable tax assets
|
30,045 | 29,316 | ||||||
Total current assets
|
3,303,822 | 2,750,848 | ||||||
EQUIPMENT, NET
|
442,270 | 469,001 | ||||||
OTHER ASSETS
|
||||||||
Intangible assets, net
|
855,689 | 1,110,111 | ||||||
Goodwill
|
983,645 | 983,645 | ||||||
Other assets
|
6,161 | 6,161 | ||||||
TOTAL ASSETS
|
$ | 5,591,587 | $ | 5,319,766 | ||||
LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Accounts payable - trade
|
$ | 2,297,387 | $ | 1,593,861 | ||||
Accounts payable - related parties
|
103,691 | 73,737 | ||||||
Accrued expenses
|
55,859 | 391,311 | ||||||
Accrued expenses - related parties
|
- | 5,849 | ||||||
Deferred revenue
|
- | 666,667 | ||||||
Convertible notes payable
|
- | 750,000 | ||||||
Derivative liability - warrants
|
4,184,000 | - | ||||||
Notes payable - current portion of long term debt
|
683,101 | 1,631,903 | ||||||
Total current liabilities
|
7,324,038 | 5,113,328 | ||||||
LONG TERM LIABILITIES:
|
||||||||
Long term debt
|
2,455 | 4,015 | ||||||
COMMITMENTS AND CONTINGENCIES
|
- | - | ||||||
STOCKHOLDERS' (DEFICIT) EQUITY:
|
||||||||
Preferred stock - $0.001 par value, 50,000,000 shares authorized, no shares
|
||||||||
issued and outstanding
|
- | - | ||||||
Common stock - $0.001 par value, 500,000,000 shares authorized, 166,677,149
|
||||||||
and 90,992,954 shares issued and outstanding at 6/30/13 and 9/30/12, respectively
|
166,679 | 90,993 | ||||||
Additional paid in capital
|
17,430,415 | 13,995,554 | ||||||
Accumulated deficit
|
(19,378,609 | ) | (13,915,931 | ) | ||||
Total stockholders' (deficit) equity
|
(1,781,515 | ) | 170,616 | |||||
Noncontrolling interest
|
46,609 | 31,807 | ||||||
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY
|
$ | 5,591,587 | $ | 5,319,766 |
VISUALANT, INC. AND SUBSIDIARIES
|
||||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS
|
||||||||||||||||
Three Months Ended,
|
Nine Months Ended,
|
|||||||||||||||
June 30, 2013
|
June 30, 2012
|
June 30, 2013
|
June 30, 2012
|
|||||||||||||
REVENUE
|
$ | 2,060,250 | $ | 1,813,625 | $ | 6,333,552 | $ | 5,525,785 | ||||||||
COST OF SALES
|
1,642,240 | 1,457,420 | 4,807,196 | 4,512,899 | ||||||||||||
GROSS PROFIT
|
418,010 | 356,205 | 1,526,356 | 1,012,886 | ||||||||||||
RESEARCH AND DEVELOPMENT EXPENSES
|
341,231 | 23,000 | 720,022 | 99,000 | ||||||||||||
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
|
1,018,083 | 1,076,134 | 3,570,911 | 2,754,050 | ||||||||||||
OPERATING LOSS
|
(941,304 | ) | (742,929 | ) | (2,764,577 | ) | (1,840,164 | ) | ||||||||
OTHER INCOME (EXPENSE):
|
||||||||||||||||
Interest expense
|
(38,605 | ) | (12,261 | ) | (154,642 | ) | (128,503 | ) | ||||||||
Other income
|
5,296 | 7,610 | 25,206 | 19,758 | ||||||||||||
Loss on change - derivative liability warrants
|
(1,448,710 | ) | - | (1,448,710 | ) | - | ||||||||||
Loss on purchase of warrants and additional investment right
|
- | - | (1,150,000 | ) | - | |||||||||||
Total other expense
|
(1,482,019 | ) | (4,651 | ) | (2,728,146 | ) | (108,745 | ) | ||||||||
LOSS BEFORE INCOME TAXES
|
(2,423,323 | ) | (747,580 | ) | (5,492,723 | ) | (1,948,909 | ) | ||||||||
Income taxes - current benefit
|
(13,910 | ) | (9,965 | ) | (30,045 | ) | (24,159 | ) | ||||||||
NET LOSS
|
(2,409,413 | ) | (737,615 | ) | (5,462,678 | ) | (1,924,750 | ) | ||||||||
NONCONTROLLING INTEREST
|
(6,476 | ) | (786 | ) | (14,802 | ) | 2,750 | |||||||||
NET (LOSS) ATTRIBUTABLE TO VISUALANT, INC. AND SUBSIDIARIES COMMON SHAREHOLDERS
|
$ | (2,402,937 | ) | $ | (736,829 | ) | $ | (5,447,876 | ) | $ | (1,927,500 | ) | ||||
Basic and diluted income (loss) per common share attributable to Visualant, Inc. and subsidiaries common shareholders-
|
||||||||||||||||
Basic and diluted income (loss) per share
|
$ | (0.02 | ) | $ | (0.01 | ) | $ | (0.05 | ) | $ | (0.03 | ) | ||||
Weighted average shares of common stock outstanding- basic and diluted
|
124,638,584 | 67,597,374 | 108,181,494 | 59,398,032 |
VISUALANT, INC. AND SUBSIDIARIES
|
||||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
||||||||
Nine Months Ended,
|
||||||||
June 30, 2013
|
June 30, 2012
|
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
Net loss
|
$ | (5,462,678 | ) | $ | (1,927,500 | ) | ||
Adjustments to reconcile net loss to net cash provided by
|
||||||||
(used in) operating activities
|
||||||||
Depreciation and amortization
|
303,270 | 258,870 | ||||||
Issuance of capital stock for services and expenses
|
254,500 | 229,000 | ||||||
Issuance of warrants for services and expenses
|
25,000 | - | ||||||
Issuance of capital stock for accrued liabilities
|
136,630 | 11,454 | ||||||
Stock based compensation
|
227,335 | 250,069 | ||||||
(Loss) on sale of assets
|
(10,572 | ) | (7,189 | ) | ||||
Loss on purchase of warrants and additional investment right
|
850,000 | - | ||||||
Loss on change - derivative liability warrants
|
1,448,710 | - | ||||||
Provision for losses on accounts receivable
|
29,281 | - | ||||||
Changes in operating assets and liabilities:
|
||||||||
Accounts receivable
|
301,700 | 111,804 | ||||||
Prepaid expenses
|
159,515 | 39,128 | ||||||
Inventory
|
(345,937 | ) | 61,114 | |||||
Accounts payable - trade and accrued expenses
|
264,039 | 478,206 | ||||||
Deferred revenue
|
(666,667 | ) | 916,667 | |||||
Income tax receivable
|
(729 | ) | (15,080 | ) | ||||
CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES
|
(2,486,603 | ) | 406,543 | |||||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
Capital expenditures
|
(23,746 | ) | 5,301 | |||||
Proceeds from sale of equipment
|
12,201 | 8,302 | ||||||
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES:
|
(11,545 | ) | 13,603 | |||||
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
Proceeds from line of credit
|
109,337 | (1,734 | ) | |||||
Repayment of debt
|
(1,899,500 | ) | (26,822 | ) | ||||
Proceeds from the issuance of common stock
|
4,852,372 | 2,626,669 | ||||||
Repayments of capital leases
|
(10,199 | ) | (9,489 | ) | ||||
Change in noncontrolling interest
|
14,802 | (15,478 | ) | |||||
NET CASH PROVIDED BY FINANCING ACTIVITIES
|
3,066,812 | 2,573,146 | ||||||
NET INCREASE IN CASH AND CASH EQUIVALENTS
|
568,664 | 2,993,292 | ||||||
CASH AND CASH EQUIVALENTS, beginning of period
|
1,141,165 | 92,313 | ||||||
CASH AND CASH EQUIVALENTS, end of period
|
$ | 1,709,829 | $ | 3,085,605 | ||||
Supplemental disclosures of cash flow information:
|
||||||||
Interest paid
|
$ | 109,545 | $ | 12,458 | ||||
Taxes paid
|
$ | - | $ | - | ||||
Non-cash investing and financing activities:
|
||||||||
Debenture converted to common stock
|
$ | 750,000 | $ | 200,000 | ||||
Note payable issued for additional investment right
|
$ | 850,000 | $ | - | ||||
Acquisition of leased equipment
|
$ | - | $ | 597 |
1.
|
ORGANIZATION
|
2.
|
GOING CONCERN
|
3.
|
SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS
|
Level 1 – Quoted prices in active markets for identical assets and liabilities;
|
Level 2 – Inputs other than level one inputs that are either directly or indirectly observable; and
|
Carrying
|
||||||||||||||||
Fair Value Measurements Using Inputs
|
Amount at
|
|||||||||||||||
Financial Instruments
|
Level 1
|
Level 2
|
Level 3
|
June 30, 2013
|
||||||||||||
Liabilities:
|
||||||||||||||||
Derivative Instruments - Warrants
|
$ | - | $ | 4,184,000 | $ | - | $ | 4,184,000 | ||||||||
Total
|
$ | - | $ | 4,184,000 | $ | - | $ | 4,184,000 |
June 30, 2013
|
||||
Market price and estimated fair value of common stock:
|
$ | 0.090 | ||
Exercise price
|
$ | 0.15-0.20 | ||
Expected term (years)
|
3-5 years
|
|||
Dividend yield
|
- | |||
Expected volatility
|
82 | % | ||
Risk-free interest rate
|
1.3 | % |
4.
|
DEVELOPMENT OF CHROMAID™ TECHNOLOGY
|
5.
|
JOINT DEVELOPMENT AGREEMENT WITH SUMITOMO PRECISION PRODUCTS CO., LTD.
|
6.
|
ACQUISITION OF TRANSTECH SYSTEMS, INC.
|
7.
|
ACCOUNTS RECEIVABLE/CUSTOMER CONCENTRATION
|
8.
|
INVENTORIES
|
9.
|
FIXED ASSETS
|
Estimated
|
June 30, 2013
|
||||||||||||
Useful Lives
|
Purchased
|
Capital Leases
|
Total
|
||||||||||
Machinery and equipment
|
2-10 years
|
$ | 119,998 | $ | 87,039 | $ | 207,037 | ||||||
Leasehold improvements
|
5-20 years
|
603,612 | - | 603,612 | |||||||||
Furniture and fixtures
|
3-10 years
|
73,539 | 101,260 | 174,799 | |||||||||
Software and websites
|
3-7 years
|
63,782 | 44,849 | 108,631 | |||||||||
Less: accumulated depreciation
|
(435,409 | ) | (216,400 | ) | (651,809 | ) | |||||||
$ | 425,522 | $ | 16,748 | $ | 442,270 |
10.
|
INTANGIBLE ASSETS
|
Estimated
|
June 30,
|
September 30,
|
|||||||
Useful Lives
|
2013
|
2012
|
|||||||
Customer contracts
|
5 years
|
$ | 983,645 | $ | 983,645 | ||||
Technology
|
5 years
|
712,500 | $ | 712,500 | |||||
Less: accumulated amortization
|
(840,456 | ) | (586,034 | ) | |||||
Intangible assets, net
|
$ | 855,689 | $ | 1,110,111 |
11.
|
ACCOUNTS PAYABLE
|
12.
|
ACCRUED EXPENSES
|
13.
|
CONVERTIBLE NOTES PAYABLE
|
14.
|
NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT
|
June 30,
|
September 30,
|
|||||||
2013
|
2012
|
|||||||
BFI Business Finance Secured Credit Facility
|
$ | 477,812 | $ | 568,475 | ||||
TransTech capitalized leases, net of capitalized interest
|
7,744 | 17,943 | ||||||
Note payable to Umpqua Bank
|
200,000 | - | ||||||
Related party notes payable-
|
||||||||
James Gingo Promissory Note
|
- | 1,000,000 | ||||||
Lynn Felsinger
|
- | 49,500 | ||||||
Total debt
|
685,556 | 1,635,918 | ||||||
Less current portion of long term debt
|
(683,101 | ) | (1,631,903 | ) | ||||
Long term debt
|
$ | 2,455 | $ | 4,015 |
Years Ended June 30,
|
Total
|
|||
2014
|
$ | 105,611 | ||
2015
|
65,292 | |||
2016
|
38,008 | |||
2017
|
- | |||
2018
|
- | |||
Beyond
|
- | |||
Total
|
$ | 208,911 |
Years Ended June 30,
|
Total
|
|||
2014
|
$ | 683,101 | ||
2015
|
2,455 | |||
2016
|
- | |||
2017
|
- | |||
2018
|
- | |||
Total
|
$ | 685,556 |
15.
|
EQUITY
|
June 30, 2013
|
||||||||
Weighted
|
||||||||
Average
|
||||||||
Exercise
|
||||||||
Shares
|
Price
|
|||||||
Outstanding at beginning of period
|
3,369,050 | $ | 0.307 | |||||
Issued
|
110,080,000 | 0.100 | ||||||
Exercised
|
- | - | ||||||
Forfeited
|
(300,000 | ) | (0.200 | ) | ||||
Expired
|
(792,000 | ) | (0.500 | ) | ||||
Outstanding at end of period
|
112,357,050 | $ | 0.173 | |||||
Exerciseable at end of period
|
112,357,050 |
June 30, 2013
|
||||||||||||||||||
Weighted
|
Weighted
|
Weighted
|
||||||||||||||||
Average
|
Average
|
Average
|
||||||||||||||||
Number of
|
Remaining
|
Exercise
|
Shares
|
Exercise
|
||||||||||||||
Warrants
|
Life
|
Price
|
Exerciseable
|
Price
|
||||||||||||||
6,080,000 | 4.37 | $ | 0.100 | 6,080,000 | $ | 0.100 | ||||||||||||
52,300,000 | 4.88 | 0.150 | 52,300,000 | 0.150 | ||||||||||||||
52,300,000 | 4.88 | 0.200 | 52,300,000 | 0.200 | ||||||||||||||
1,059,073 | 0.62 | 0.20-0.29 | 1,059,073 | 0.20-0.29 | ||||||||||||||
117,977 | 0.80 | 0.30-0.39 | 117,977 | 0.30-0.39 | ||||||||||||||
500,000 | 0.63 | 0.40-0.49 | 500,000 | 0.40-0.49 | ||||||||||||||
112,357,050 | 4.75 | $ | 0.173 | 112,357,050 | $ | 0.173 |
Dividend yield
|
0%
|
Expected life
|
3-5 years
|
Expected volatility
|
143%
|
Risk free interest rate
|
1.5%
|
16.
|
STOCK OPTIONS
|
Weighted Average
|
||||||||||||
Options
|
Exercise Price
|
$ | ||||||||||
Outstanding as of September 30, 2011
|
6,920,000 | $ | 0.296 | $ | 2,050,800 | |||||||
Granted
|
2,200,000 | 0.104 | 229,000 | |||||||||
Exercised
|
- | - | - | |||||||||
Forfeitures
|
(3,200,000 | ) | 0.470 | (1,503,000 | ) | |||||||
Outstanding as of September 30, 2012
|
5,920,000 | 0.131 | $ | 776,800 | ||||||||
Granted
|
5,100,000 | 0.130 | 663,000 | |||||||||
Exercised
|
- | - | - | |||||||||
Forfeitures
|
(15,000 | ) | 0.240 | (3,600 | ) | |||||||
Outstanding as of June 30, 2013
|
11,005,000 | $ | 0.131 | 1,436,200 |
Weighted
|
Weighted
|
Weighted
|
|||||||||||||||||
Average
|
Average
|
Average
|
|||||||||||||||||
Range of
|
Number
|
Remaining Life
|
Exercise Price
|
Number
|
Exercise Price
|
||||||||||||||
Exercise Prices
|
Outstanding
|
In Years
|
Exerciseable
|
Exerciseable
|
Exerciseable
|
||||||||||||||
0.090 | 500,000 |
6.50 years
|
0.090 | 375,000 | 0.090 | ||||||||||||||
0.100 | 1,900,000 |
8.25 years
|
0.100 | 2,000,000 | 0.100 | ||||||||||||||
0.120 | 200,000 |
1.00 years
|
0.120 | 100,000 | 0.120 | ||||||||||||||
0.130 | 5,100,000 |
6.43 years
|
0.130 | 3,633,333 | 0.130 | ||||||||||||||
0.150 | 3,100,000 |
6.55 years
|
0.150 | 3,100,000 | 0.150 | ||||||||||||||
0.240 | 205,000 |
2.00 years
|
0.240 | 165,000 | 0.240 | ||||||||||||||
11,005,000 |
7.29 years
|
$ | 0.131 | 9,373,333 | $ | 0.135 |
17.
|
OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES
|
18.
|
COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS
|
Years Ended June 30,
|
Total
|
|||
2014
|
$ | 105,611 | ||
2015
|
65,292 | |||
2016
|
38,008 | |||
2017
|
- | |||
2018
|
- | |||
Beyond
|
- | |||
Total
|
$ | 208,911 |
19.
|
SUBSEQUENT EVENTS
|
ITEM 2.
|
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
|
-
|
Powders for law enforcement applications,
|
|
-
|
Drugs and drug container seals for protection against contamination and counterfeiting for pharmaceutical applications.
|
|
-
|
Fruit and vegetable ripeness for agriculture applications,
|
|
-
|
Noninvasive skin analysis for discovery of certain diseases or conditions for medical applications.
|
|
-
|
ChromaID F12 Scanner. A small device made with electronic, optical, and software parts which shine light onto a flat material and measures the amount of light that is reflected back. The device is the size of a flashlight (5.5” long and 1.25” diameter).
|
|
-
|
ChromaID Lab Software. A software application that runs on a Windows Personal Computer. This software configures and controls the ChromaID F12 Scanner, displays the captured ChromaID Profile, and compares it to known ChromaID Profiles.
|
|
-
|
Sale of the ChromaID F12 Lab Kit and ChromaID Developer Tools.
|
|
-
|
Licensing of the ChromaID technology,
|
|
-
|
Sales of the Scanhead and associated licensing and royalties.
|
|
-
|
ChromaID database administration and management services.
|
Three Months Ended June 30,
|
|||||||||||||||||
2013
|
2012
|
$ Variance
|
% Variance
|
||||||||||||||
Revenue
|
$ | 2,060 | $ | 1,814 | $ | 246 | 13.6 | % | |||||||||
Cost of sales
|
1,642 | 1,458 | 184 | -12.6 | % | ||||||||||||
Gross profit
|
418 | 356 | 62 | 17.4 | % | ||||||||||||
Research and development expenses
|
341 | 23 | 318 | -1382.6 | % | ||||||||||||
Selling, general and administrative expenses
|
1,018 | 1,076 | (58 | ) | 5.4 | % | |||||||||||
Operating loss
|
(941 | ) | (743 | ) | (198 | ) | -26.6 | % | |||||||||
Other income (expense):
|
|||||||||||||||||
Interest expense
|
(38 | ) | (12 | ) | (26 | ) | -216.7 | % | |||||||||
Other income
|
5 | 7 | (2 | ) | -28.6 | % | |||||||||||
Loss on change- derivative liability warrants
|
(1,449 | ) | - | (1,449 | ) | -100.0 | % | ||||||||||
Total other expense
|
(1,482 | ) | (5 | ) | (1,477 | ) | -29540.0 | % | |||||||||
Loss before income taxes
|
(2,423 | ) | (748 | ) | (1,675 | ) | -223.9 | % | |||||||||
Income taxes - current benefit
|
(14 | ) | (10 | ) | (4 | ) | 40.0 | % | |||||||||
Net loss
|
(2,409 | ) | (738 | ) | (1,671 | ) | -226.4 | % | |||||||||
Non-controlling interest
|
(6 | ) | (1 | ) | (5 | ) | -500.0 | % | |||||||||
Net loss attributable to Visualant, Inc. common shareholders
|
$ | (2,403 | ) | $ | (737 | ) | $ | (1,666 | ) | -226.1 | % |
Nine Months Ended June 30,
|
|||||||||||||||||
2013
|
2012
|
$ Variance
|
% Variance
|
||||||||||||||
Revenue
|
$ | 6,334 | $ | 5,526 | $ | 808 | 14.6 | % | |||||||||
Cost of sales
|
4,807 | 4,513 | 294 | -6.5 | % | ||||||||||||
Gross profit
|
1,527 | 1,013 | 514 | 50.7 | % | ||||||||||||
Research and development expenses
|
720 | 99 | 621 | -627.3 | % | ||||||||||||
Selling, general and administrative expenses
|
3,572 | 2,754 | 818 | -29.7 | % | ||||||||||||
Operating loss
|
(2,765 | ) | (1,840 | ) | (925 | ) | -50.3 | % | |||||||||
Other income (expense):
|
|||||||||||||||||
Interest expense
|
(154 | ) | (129 | ) | (25 | ) | -19.4 | % | |||||||||
Other income
|
25 | 20 | 5 | 25.0 | % | ||||||||||||
Loss on change- derivative liability warrants
|
(1,449 | ) | - | (1,449 | ) | -100.0 | % | ||||||||||
Loss on purchase of warrants and additional investment right
|
(1,150 | ) | - | (1,150 | ) | -100.0 | % | ||||||||||
Total other expense
|
(2,728 | ) | (109 | ) | (2,619 | ) | -2402.8 | % | |||||||||
Loss before income taxes
|
(5,493 | ) | (1,949 | ) | (3,544 | ) | -181.8 | % | |||||||||
Income taxes - current benefit
|
(30 | ) | (24 | ) | (6 | ) | 25.0 | % | |||||||||
Net loss
|
(5,463 | ) | (1,925 | ) | (3,538 | ) | -183.8 | % | |||||||||
Non-controlling interest
|
(15 | ) | 3 | (18 | ) | 600.0 | % | ||||||||||
Net loss attributable to Visualant, Inc. common shareholders
|
$ | (5,448 | ) | $ | (1,928 | ) | $ | (3,520 | ) | -182.6 | % |
Less Than
|
Greater Than
|
|||||||||||||||||||
Contractual Cash Obligations
|
Total
|
1 Year
|
1-3 Years
|
3-5 Years
|
5 Years
|
|||||||||||||||
Operating leases
|
$ | 208,911 | $ | 105,611 | $ | 103,300 | $ | 0 | $ | 0 | ||||||||||
Notes payable
|
685,556 | 683,101 | 2,455 | 0 | 0 | |||||||||||||||
Capital expenditures
|
375,000 | 75,000 | 150,000 | 150,000 | 0 | |||||||||||||||
$ | 1,269,467 | $ | 863,712 | $ | 255,755 | $ | 150,000 | $ | 0 |
ITEM 3.
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
|
ITEM 4.
|
CONTROLS AND PROCEDURES
|
ITEM 1A.
|
RISK FACTORS
|
•
|
Announcements by us regarding liquidity, significant acquisitions, equity investments and divestitures, strategic relationships, addition or loss of significant customers and contracts, capital expenditure commitments and litigation;
|
|
•
|
Issuance of convertible or equity securities and related warrants for general or merger and acquisition purposes;
|
|
•
|
Issuance or repayment of debt, accounts payable or convertible debt for general or merger and acquisition purposes;
|
|
•
|
Sale of a significant number of shares of our common stock by shareholders;
|
|
•
|
General market and economic conditions;
|
|
•
|
Quarterly variations in our operating results;
|
|
•
|
Investor and public relation activities;
|
|
•
|
Announcements of technological innovations;
|
|
•
|
New product introductions by us or our competitors;
|
|
•
|
Competitive activities; and
|
|
•
|
Additions or departures of key personnel.
|
•
|
any of our existing patents will continue to be held valid, if challenged;
|
•
|
patents will be issued for any of our pending applications;
|
•
|
any claims allowed from existing or pending patents will have sufficient scope or strength to protect us;
|
•
|
our patents will be issued in the primary countries where our products are sold in order to protect our rights and potential commercial advantage; or
|
•
|
any of our products or technologies will not infringe on the patents of other companies.
|
ITEM 2.
|
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
|
ITEM 5.
|
OTHER INFORMATION
|
ITEM 6.
|
EXHIBITS AND REPORTS ON FORM 8-K
|
10.1
|
Amendment to Joint Research and Product Development Agreement dated March 29, 2013 by and between Visualant,Inc. and Sumitomo Precision Products Co., Ltd. (1)
|
10.2
|
Option Agreement dated April 26, 2013 by and between Visualant, Inc. and Ascendiant Capital Partners LLC. (2)
|
10.4
|
Form of Purchase Agreement by and between Visualant, Inc. and investors. (3)
|
10.5
|
Form of Warrant by and between Visualant, Inc. and investors. (3)
|
10.6
|
Form of Registration Rights Agreement by and between Visualant, Inc. and investors. (3)
|
10.7
|
Form of Voting Agreement by and between Visualant, Inc. and investors. (3)
|
101
|
Interactive data files pursuant to Rule 405 of Regulation S-T. (5)
|
Date: August 14, 2013
|
By:
|
/s/ Ronald P. Erickson
|
|
Ronald P. Erickson
|
|||
Chief Executive Officer, President, and Director
|
|||
(Principal Executive Officer)
|
Date: August 14, 2013
|
By:
|
/s/ Mark Scott
|
|
Mark Scott
|
|||
Chief Financial Officer, Secretary and Treasurer
|
|||
(Principal Financial and Accounting Officer)
|
USD $585,000
|
Seattle, WA
|
MAKER:
|
||
VISUALANT, INC.
|
||
|
/s/ Mark Scott | |
By: Mark Scott
|
||
Its: Chief Financial Officer
|
||
|
If to Guarantor/Pledgor:
|
VISUALANT, INCORPORATED
500 Union Street, Suite 420, Seattle, Washington 98101
|
|
Attn:
|
Ronald P. Erickson, President
|
|
Telephone No.:
|
(206) 903-1351
|
|
Facsimile No.:
|
______________
|
|
If to Lender:
|
BFI Business Finance
851 East Hamilton Avenue, Second Floor, Campbell, California 95008
|
|
Attn:
|
David Drogos, President
|
|
Telephone No.:
|
(408) 369-4000
|
|
Facsimile No.:
|
(408) 369-4018
|
VISUALANT, INCORPORATED
|
|||
|
/s/ Mark Scott | ||
By: | Mark E. Scott | ||
Title: | Secretary | ||
Accepted at Campbell, California:
|
|||
BFI Business Finance
|
|||
|
/s/ Jeffrey Lizar | ||
By: | Jeffrey Lizar | ||
Title: | Executive Vice President | ||
12. ACCRUED EXPENSES
|
9 Months Ended |
---|---|
Jun. 30, 2013
|
|
Notes to Financial Statements | |
12. ACCRUED EXPENSES | Accrued expenses were $55,859 and $391,311 as of June 30, 2013 and September 30, 2012, respectively. As of September 30, 2012 liabilities consisted of accrued interest and $250,000 due to Gemini Master Fund, Ltd. for the repurchase of a warrant under a Warrant Repurchase Agreement dated August 28, 2012.
|
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
|
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2013
|
Jun. 30, 2012
|
Jun. 30, 2013
|
Jun. 30, 2012
|
|
Income Statement [Abstract] | ||||
REVENUE | $ 2,060,250 | $ 1,813,625 | $ 6,333,552 | $ 5,525,785 |
COST OF SALES | 1,642,240 | 1,457,420 | 4,807,196 | 4,512,899 |
GROSS PROFIT | 418,010 | 356,205 | 1,526,356 | 1,012,886 |
RESEARCH AND DEVELOPMENT EXPENSES | 341,231 | 23,000 | 720,022 | 99,000 |
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES | 1,018,083 | 1,076,134 | 3,570,911 | 2,754,050 |
OPERATING LOSS | (941,304) | (742,929) | (2,764,577) | (1,840,164) |
OTHER INCOME (EXPENSE) | ||||
Interest expense | (38,605) | (12,261) | (154,642) | (128,503) |
Other income | 5,296 | 7,610 | 25,206 | 19,758 |
Loss on change - derivative liability warrants | (1,448,710) | (1,448,710) | ||
Loss on purchase of warrants and additional investment right | (1,150,000) | |||
Total other expense | (1,482,019) | (4,651) | (2,728,146) | (108,745) |
LOSS BEFORE INCOME TAXES | (2,423,323) | (747,580) | (5,492,723) | (1,948,909) |
Income taxes - current benefit | (13,910) | (9,965) | (30,045) | (24,159) |
NET LOSS | (2,409,413) | (737,615) | (5,462,678) | (1,924,750) |
NONCONTROLLING INTEREST | (6,476) | (786) | (14,802) | 2,750 |
NET LOSS ATTRIBUTABLE TO VISUALANT, INC. AND SUBSIDIARIES COMMON SHAREHOLDERS | $ (2,402,937) | $ (736,829) | $ (5,447,876) | $ (1,927,500) |
Basic and diluted loss per common share attributable to Visualant, Inc. and subsidiaries common shareholders- | ||||
Basic and diluted loss per share | $ (0.02) | $ (0.01) | $ (0.05) | $ (0.03) |
Weighted average shares of common stock outstanding- basic and diluted | 124,638,584 | 67,597,374 | 108,181,494 | 59,398,032 |
5. JOINT DEVELOPMENT AGREEMENT WITH SUMITOMO PRECISION PRODUCTS CO., LTD.
|
9 Months Ended |
---|---|
Jun. 30, 2013
|
|
Notes to Financial Statements | |
5. JOINT DEVELOPMENT AGREEMENT WITH SUMITOMO PRECISION PRODUCTS CO., LTD. | On May 31, 2012, the Company entered into a Joint Research and Product Development Agreement with SPP, a publicly-traded Japanese corporation, for the commercialization of our ChromaID technology. On March 29, 2013, the Company entered into an Amendment to Joint Research and Product Development Agreement with SPP. The Amended Agreement extends the Joint Development Agreement from March 31, 2013 to December 31, 2013 and focuses on the commercialization of our ChromaID technology.
SPP invested $2,250,000 in exchange for 17,307,693 shares of restricted common shares priced at $0.13 per share that was funded on June 21, 2012. SPP also paid the Company an initial payment of $1 million for an exclusive License Agreement which covers select countries in Asia. A running royalty for the license granted under the License Agreement will be negotiated at the completion of the Joint Development Agreement. The SPP License fee was recorded as revenue over the life the Joint Development Agreement and was fully recorded as of May 31, 2013.
SPP is publicly traded in Japan and has operations in Japan, United States, China, United Kingdom, Canada and other parts of the world. |
19. SUBSEQUENT EVENTS
|
9 Months Ended |
---|---|
Jun. 30, 2013
|
|
Subsequent Events [Abstract] | |
19. SUBSEQUENT EVENTS | The Company evaluates subsequent events, for the purpose of adjustment or disclosure, up through the date the financial statements are available.
Subsequent to June 30, 2013, the following material transactions occurred:
On July 3, 2013, the Company filed a registration statement on Form S-1 covering 70,300,000 shares. The common stock being registered for resale consists of (i) 52,300,000 shares of common stock issued to Special Situations and forty other accredited investors (collectively, the Investors) pursuant to a Private Placement which closed June 14, 2013; and (ii) 18,000,000 shares of common stock issuable upon exercise of a portion of the five-year Warrants to purchase shares of common stock at $0.15 per share issued as part of the above-referenced Private Placement.
At a special meeting of shareholders held on August 9, 2013 the stockholders of the Company approved of an increase in the authorized shares of common stock from 200,000,000 to 500,000,000 and thereafter to amend the articles of the Company to reflect this change in share authorization. |
13. CONVERTIBLE NOTES PAYABLE
|
9 Months Ended |
---|---|
Jun. 30, 2013
|
|
Notes to Financial Statements | |
13. CONVERTIBLE NOTES PAYABLE | Agreements with Gemini Master Fund, Ltd. and Ascendiant Capital Partners, LLC
On May 31, 2013, the Company paid $250,000 plus interest of $35,175 under the Amendment to Warrant Purchase Agreement with Gemini dated January 23, 2013. The Company has acquired the warrant from Gemini and cancelled it.
On June 26, 2013, the Company acquired all additional investment rights (AIR) between the Company and Gemini under the AIR Agreement dated January 23, 2013 with the payment of $850,000 and interest of $17,349.
The Companys equity line of credit with Ascendiant remains outstanding, with available credit of $2,516,859. The Company has no current intention to utilize this line of credit, which expires August 29, 2013.
|
15. EQUITY (Details) (USD $)
|
9 Months Ended |
---|---|
Jun. 30, 2013
|
|
Shares | |
Outstanding at beginning of period | 3,369,050 |
Issued | 110,080,000 |
Exercised | |
Forfeited | (300,000) |
Expired | (792,000) |
Outstanding at end of period | 112,357,050 |
Exerciseable at end of period | 112,357,050 |
Weighted Average Exercise Price: | |
Outstanding at beginning of period | $ 0.307 |
Issued | $ 0.1 |
Exercised | |
Forfeited | $ (0.200) |
Expired | $ (0.500) |
Outstanding at end of period | $ 0.173 |
8. INVENTORIES (Details Narrative) (USD $)
|
Jun. 30, 2013
|
Sep. 30, 2012
|
---|---|---|
Notes to Financial Statements | ||
Inventories | $ 690,629 | $ 344,692 |
Reserve for impaired inventory | $ 10,000 | $ 10,000 |
9. FIXED ASSETS (Tables)
|
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Notes to Financial Statements | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Property and equipment | Property and equipment as of June 30, 2013 consisted of the following:
|
3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS (Tables)
|
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Notes to Financial Statements | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unobservable inputs developed using estimates and assumptions | Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair value on a recurring basis | Liabilities measured at fair value on a recurring basis are summarized as follows:
|
14. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT (Details 1) (USD $)
|
Jun. 30, 2013
|
---|---|
Notes to Financial Statements | |
2014 | $ 105,611 |
2015 | 65,292 |
2016 | 38,008 |
2017 | |
2018 | |
Beyond | |
Total | $ 208,911 |
3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS (Details) (USD $)
|
Jun. 30, 2013
|
---|---|
Fair Value Measurements Level 1 [Member]
|
|
Liabilities: | |
Derivative Instruments - Warrants | |
Total | |
Fair Value Measurements Level 2 [Member]
|
|
Liabilities: | |
Derivative Instruments - Warrants | 4,184,000 |
Total | 4,184,000 |
Fair Value Measurements Level 3 [Member]
|
|
Liabilities: | |
Derivative Instruments - Warrants | |
Total | |
Carrying Value [Member]
|
|
Liabilities: | |
Derivative Instruments - Warrants | 4,184,000 |
Total | $ 4,184,000 |
9. FIXED ASSETS (Details Narrative) (USD $)
|
9 Months Ended | ||
---|---|---|---|
Jun. 30, 2013
|
Jun. 30, 2012
|
Sep. 30, 2012
|
|
Notes to Financial Statements | |||
Property and equipment, net | $ 442,270 | $ 469,001 | |
Property and equipment, accumulated depreciation | 651,809 | 606,509 | |
Depreciation expense | $ 49,160 | $ 43,823 |
16. STOCK OPTIONS (Tables)
|
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Notes to Financial Statements | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock option activity | Stock option activity for the nine months ended June 30, 2013 and the year ended September 30, 2012:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock options outstanding and exercisable | The following table summarizes information about stock options outstanding and exercisable at June 30, 2013:
|
11. ACCOUNTS PAYABLE (Details Narrative) (USD $)
|
Jun. 30, 2013
|
Sep. 30, 2012
|
---|---|---|
Notes to Financial Statements | ||
Accounts payable | $ 2,297,387 | $ 1,593,861 |
Vendor1 with accounts payble on excess of 10% | 37.50% | |
Vendor2 with accounts payble on excess of 10% | 19.20% | |
Vendor3 with accounts payble on excess of 10% | 11.60% |
3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS (Policies)
|
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Notes to Financial Statements | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PRINCIPLES OF CONSOLIDATION | The consolidated financial statements include the accounts of the Company and its wholly owned and majority-owned subsidiaries. Inter-Company items and transactions have been eliminated in consolidation. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CASH AND CASH EQUIVALENTS | The Company classifies highly liquid temporary investments with an original maturity of three months or less when purchased as cash equivalents. The Company maintains cash balances at various financial institutions. Balances at US banks are insured by the Federal Deposit Insurance Corporation up to $250,000. Beginning December 31, 2010 and through December 31, 2013, all noninterest-bearing transaction accounts are fully insured, regardless of the balance of the account, at all FDIC-insured institutions. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk for cash on deposit. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS | Accounts receivable consist primarily of amounts due to the Company from normal business activities. The Company maintains an allowance for doubtful accounts to reflect the expected non-collection of accounts receivable based on past collection history and specific risks identified within the portfolio. If the financial condition of the customers were to deteriorate resulting in an impairment of their ability to make payments, or if payments from customers are significantly delayed, additional allowances might be required. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INVENTORIES | Inventories consist primarily of printers and consumable supplies, including ribbons and cards, badge accessories, capture devices, and access control components held for resale and are stated at the lower of cost or market on the first-in, first-out (FIFO) method. Inventories are considered available for resale when drop shipped and invoiced directly to a customer from a vendor, or when physically received by TransTech at a warehouse location. The company records a provision for excess and obsolete inventory whenever an impairment has been identified. There is a $10,000 reserve for impaired inventory as of June 30, 2013 and September 30, 2012. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EQUIPMENT | Equipment consists of machinery, leasehold improvements, furniture and fixtures and software, which are stated at cost less accumulated depreciation and amortization. Depreciation is computed by the straight-line method over the estimated useful lives or lease period of the relevant asset, generally 2-10 years, except for leasehold improvements which are depreciated over 5-20 years. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INTANGIBLE ASSETS / INTELLECTUAL PROPERTY | The Company amortizes the intangible assets and intellectual property acquired in connection with the acquisition of TransTech, over sixty months on a straight - line basis, which was the time frame that the management of the Company was able to project forward for future revenue, either under agreement or through expected continued business activities. Intangible assets and intellectual property acquired from RATLab LLC and Javelin are recorded likewise. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GOODWILL | Goodwill is the excess of cost of an acquired entity over the fair value of amounts assigned to assets acquired and liabilities assumed in a business combination. With the adoption of ASC 350, goodwill is not amortized, rather it is tested for impairment annually, and will be tested for impairment between annual tests if an event occurs or circumstances change that would indicate the carrying amount may be impaired. Impairment testing for goodwill is done at a reporting unit level. Reporting units are one level below the business segment level, but are combined when reporting units within the same segment have similar economic characteristics. Under the criteria set forth by ASC 350, the Company has one reporting unit based on the current structure. An impairment loss generally would be recognized when the carrying amount of the reporting units net assets exceeds the estimated fair value of the reporting unit. The Company performs annual assessments and has determined that no impairment is necessary. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LONG-LIVED ASSETS | The Company reviews its long-lived assets for impairment when changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived assets under certain circumstances are reported at the lower of carrying amount or fair value. Assets to be disposed of and assets not expected to provide any future service potential to the Company are recorded at the lower of carrying amount or fair value (less the projected cost associated with selling the asset). To the extent carrying values exceed fair values, an impairment loss is recognized in operating results. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FAIR VALUE MEASUREMENTS AND FINANCIAL INSTRUMENTS | ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy, which requires classification based on observable and unobservable inputs when measuring fair value. The fair value hierarchy distinguishes between assumptions based on market data (observable inputs) and an entitys own assumptions (unobservable inputs). The hierarchy consists of three levels:
Level 3 Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.
Liabilities measured at fair value on a recurring basis are summarized as follows:
The risk-free rate of return reflects the interest rate for the United States Treasury Note with similar time-to-maturity to that of the warrants.
Derivative Instruments - Warrants The Company issued 104,600,000 warrants in connection with the June 2013 Private Placement of 52,300,000 shares of common stock. The strike price of these warrants is $0.15 to $0.20 per share. These warrants were not issued with the intent of effectively hedging any future cash flow, fair value of any asset, liability or any net investment in a foreign operation. These warrants were issued with a down-round provision whereby the exercise price would be adjusted downward in the event that additional shares of the Companys common stock or securities exercisable, convertible or exchangeable for the Companys common stock were issued at a price less than the exercise price. Therefore, the fair value of these warrants were recorded as a liability in the consolidated balance sheet and are marked to market each reporting period until they are exercised or expire or otherwise extinguished.
The proceeds from the Private Placement were allocated between the Common Shares and the Warrants issued in connection with the Private Placement based upon their estimated fair values as of the closing date at June 14, 2013, resulting in the aggregate amount of $2,494,710 to the Stockholders Equity and $2,735,290 to the warrant derivative. During 2013, the Company recognized $1,448,710 of other expense resulting from the increase in the fair value of the warrant liability at June 30, 2013.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REVENUE RECOGNITION | TransTech revenue is derived from other products and services. Revenue is considered realized when the services have been provided to the customer, the work has been accepted by the customer and collectability is reasonably assured. Furthermore, if an actual measurement of revenue cannot be determined, we defer all revenue recognition until such time that an actual measurement can be determined. If during the course of a contract management determines that losses are expected to be incurred, such costs are charged to operations in the period such losses are determined. Revenues are deferred when cash has been received from the customer but the revenue has not been earned. The SPP License fee is being recorded as revenue over the life the Joint Development Agreement discussed below. The Company recorded deferred revenue of $0 and $666,667 as of June 30, 2013 and September 30, 2012, respectively. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
STOCK BASED COMPENSATION | The Company has share-based compensation plans under which employees, consultants, suppliers and directors may be granted restricted stock, as well as options to purchase shares of Company common stock at the fair market value at the time of grant. Stock-based compensation cost is measured by the Company at the grant date, based on the fair value of the award, over the requisite service period. For options issued to employees, the Company recognizes stock compensation costs utilizing the fair value methodology over the related period of benefit. Grants of stock options and stock to non-employees and other parties are accounted for in accordance with the ASC 505. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INCOME TAXES | Income tax benefit is based on reported loss before income taxes. Deferred income taxes reflect the effect of temporary differences between asset and liability amounts that are recognized for financial reporting purposes and the amounts that are recognized for income tax purposes. These deferred taxes are measured by applying currently enacted tax laws where that company operates out of. The Company recognizes refundable and deferred assets to the extent that management has determined their realization. As of June 30, 2013 and September 30, 2012, the Company had refundable tax assets related to TransTech of $30,045 and $29,316, respectively.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NET LOSS PER SHARE | Under the provisions of ASC 260, Earnings Per Share, basic loss per common share is computed by dividing net loss available to common shareholders by the weighted average number of shares of common stock outstanding for the periods presented. Diluted net loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that would then share in the income of the Company, subject to anti-dilution limitations. The common stock equivalents have not been included as they are anti-dilutive. As of June 30, 2013, there were options outstanding for the purchase of 11,005,000 common shares, warrants for the purchase of 112,357,050 common shares, and an undetermined number shares of common stock related to convertible debt, which could potentially dilute future earnings per share. As of June 30, 2012, there were options outstanding for the purchase of 9,020,000 common shares, warrants for the purchase of 4,977,051 common shares, and an undetermined number shares of common stock related to convertible debt, which could potentially dilute future earnings per share. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DIVIDEND POLICY | The Company has never paid any cash dividends and intends, for the foreseeable future, to retain any future earnings for the development of our business. Our future dividend policy will be determined by the board of directors on the basis of various factors, including our results of operations, financial condition, capital requirements and investment opportunities. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
USE OF ESTIMATES | The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RECENT ACCOUNTING PRONOUNCEMENTS | A variety of proposed or otherwise potential accounting standards are currently under study by standard setting organizations and various regulatory agencies. Due to the tentative and preliminary nature of those proposed standards, management has not determined whether implementation of such proposed standards would be material to our consolidated financial statements. |
1. ORGANIZATION
|
9 Months Ended |
---|---|
Jun. 30, 2013
|
|
Notes to Financial Statements | |
1. ORGANIZATION |
Visualant, Inc. (the Company or Visualant) was incorporated under the laws of the State of Nevada on October 8, 1998 with authorized common stock of 500,000,000 shares at $0.001 par value. On September 13, 2002, 50,000,000 shares of preferred stock with a par value of $0.001 were authorized by the shareholders. There are no preferred shares issued and the terms have not been determined. The Companys executive offices are located in Seattle, Washington.
The Company has invented a way to shine light at a material (solid surface, liquid, or gas) and measure the amount of light that is reflected back. The pattern of this reflected light is compared to other patterns the Company has captured and this allows the Company to identify, detect, or diagnose materials that cannot be identified by the human eye. The Company refers to this pattern of reflected light as a ChromaID. The Company designs ChromaID Scanner devices made with electronic, optical, and software parts to produce and capture the light.
The Companys first product, the ChromaID F12 Lab Kit, scans and identifies solid surfaces. The Company is marketing this product to customers who are considering licensing the technology. Target markets include, but are not limited to, commercial paint manufacturers, pharmaceutical equipment manufacturers, process control companies, currency paper and ink manufacturers, security card, reader, and scanner manufacturers, food processing, and electronic gaming.
Through our wholly owned subsidiary, TransTech Systems, Inc., based in Aurora, Oregon, the Company provides value added security and authentication solutions to corporate and government security and law enforcement markets throughout the United States.
On June 10, 2013, the Company entered into a Purchase Agreement, Warrants, Registration Rights Agreement and Voting Agreement with Special Situations and forty other accredited investors pursuant to which we issued 52,300,000 shares of common stock at $0.10 per share for a total of $5,230,000, which amount includes the conversion of $500,000 in outstanding debt of the Company owed to one of its officers. As part of the transaction which closed on June 14, 2013, the Company issued to the investors (i) five year Series A Warrants to purchase a total of 52,300,000 shares of common stock at $0.15 per share; and (ii) five year Series B Warrants to purchase a total of 52,300,000 shares of common stock at $0.20 per share. The transaction was entered into to strengthen our balance sheet, complete the purchase of our TransTech subsidiary, and provide working capital to support the rapid movement of our ChromaID technology into the marketplace.
The Company has a Joint Development Agreement through December 31, 2013 with Sumitomo Precision Products Co., Ltd., which focuses on the commercialization of the ChromaID technology as well as a License Agreement providing SPP with an exclusive license of the ChromaID technology in identified Asian territories. SPP is publicly traded in Japan and has operations in Japan, United States, China, United Kingdom, Canada and other parts of the world.
To date, the Company been issued five patents by the United States Office of Patents and Trademarks. See page 9 for more detailed information regarding the Company's patents and business.
|
3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS
|
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Notes to Financial Statements | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS | PRINCIPLES OF CONSOLIDATION - The consolidated financial statements include the accounts of the Company and its wholly owned and majority-owned subsidiaries. Inter-Company items and transactions have been eliminated in consolidation.
CASH AND CASH EQUIVALENTS - The Company classifies highly liquid temporary investments with an original maturity of three months or less when purchased as cash equivalents. The Company maintains cash balances at various financial institutions. Balances at US banks are insured by the Federal Deposit Insurance Corporation up to $250,000. Beginning December 31, 2010 and through December 31, 2013, all noninterest-bearing transaction accounts are fully insured, regardless of the balance of the account, at all FDIC-insured institutions. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk for cash on deposit.
ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS - Accounts receivable consist primarily of amounts due to the Company from normal business activities. The Company maintains an allowance for doubtful accounts to reflect the expected non-collection of accounts receivable based on past collection history and specific risks identified within the portfolio. If the financial condition of the customers were to deteriorate resulting in an impairment of their ability to make payments, or if payments from customers are significantly delayed, additional allowances might be required.
INVENTORIES - Inventories consist primarily of printers and consumable supplies, including ribbons and cards, badge accessories, capture devices, and access control components held for resale and are stated at the lower of cost or market on the first-in, first-out (FIFO) method. Inventories are considered available for resale when drop shipped and invoiced directly to a customer from a vendor, or when physically received by TransTech at a warehouse location. The company records a provision for excess and obsolete inventory whenever an impairment has been identified. There is a $10,000 reserve for impaired inventory as of June 30, 2013 and September 30, 2012.
EQUIPMENT - Equipment consists of machinery, leasehold improvements, furniture and fixtures and software, which are stated at cost less accumulated depreciation and amortization. Depreciation is computed by the straight-line method over the estimated useful lives or lease period of the relevant asset, generally 2-10 years, except for leasehold improvements which are depreciated over 5-20 years.
INTANGIBLE ASSETS / INTELLECTUAL PROPERTY The Company amortizes the intangible assets and intellectual property acquired in connection with the acquisition of TransTech, over sixty months on a straight - line basis, which was the time frame that the management of the Company was able to project forward for future revenue, either under agreement or through expected continued business activities. Intangible assets and intellectual property acquired from RATLab LLC and Javelin are recorded likewise.
GOODWILL Goodwill is the excess of cost of an acquired entity over the fair value of amounts assigned to assets acquired and liabilities assumed in a business combination. With the adoption of ASC 350, goodwill is not amortized, rather it is tested for impairment annually, and will be tested for impairment between annual tests if an event occurs or circumstances change that would indicate the carrying amount may be impaired. Impairment testing for goodwill is done at a reporting unit level. Reporting units are one level below the business segment level, but are combined when reporting units within the same segment have similar economic characteristics. Under the criteria set forth by ASC 350, the Company has one reporting unit based on the current structure. An impairment loss generally would be recognized when the carrying amount of the reporting units net assets exceeds the estimated fair value of the reporting unit. The Company performs annual assessments and has determined that no impairment is necessary.
LONG-LIVED ASSETS The Company reviews its long-lived assets for impairment when changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived assets under certain circumstances are reported at the lower of carrying amount or fair value. Assets to be disposed of and assets not expected to provide any future service potential to the Company are recorded at the lower of carrying amount or fair value (less the projected cost associated with selling the asset). To the extent carrying values exceed fair values, an impairment loss is recognized in operating results.
FAIR VALUE MEASUREMENTS AND FINANCIAL INSTRUMENTS ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy, which requires classification based on observable and unobservable inputs when measuring fair value. The fair value hierarchy distinguishes between assumptions based on market data (observable inputs) and an entitys own assumptions (unobservable inputs). The hierarchy consists of three levels:
Level 3 Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.
Liabilities measured at fair value on a recurring basis are summarized as follows:
The risk-free rate of return reflects the interest rate for the United States Treasury Note with similar time-to-maturity to that of the warrants.
Derivative Instruments - Warrants The Company issued 104,600,000 warrants in connection with the June 2013 Private Placement of 52,300,000 shares of common stock. The strike price of these warrants is $0.15 to $0.20 per share. These warrants were not issued with the intent of effectively hedging any future cash flow, fair value of any asset, liability or any net investment in a foreign operation. These warrants were issued with a down-round provision whereby the exercise price would be adjusted downward in the event that additional shares of the Companys common stock or securities exercisable, convertible or exchangeable for the Companys common stock were issued at a price less than the exercise price. Therefore, the fair value of these warrants were recorded as a liability in the consolidated balance sheet and are marked to market each reporting period until they are exercised or expire or otherwise extinguished.
The proceeds from the Private Placement were allocated between the Common Shares and the Warrants issued in connection with the Private Placement based upon their estimated fair values as of the closing date at June 14, 2013, resulting in the aggregate amount of $2,494,710 to the Stockholders Equity and $2,735,290 to the warrant derivative. During 2013, the Company recognized $1,448,710 of other expense resulting from the increase in the fair value of the warrant liability at June 30, 2013.
REVENUE RECOGNITION TransTech revenue is derived from other products and services. Revenue is considered realized when the services have been provided to the customer, the work has been accepted by the customer and collectability is reasonably assured. Furthermore, if an actual measurement of revenue cannot be determined, we defer all revenue recognition until such time that an actual measurement can be determined. If during the course of a contract management determines that losses are expected to be incurred, such costs are charged to operations in the period such losses are determined. Revenues are deferred when cash has been received from the customer but the revenue has not been earned. The SPP License fee is being recorded as revenue over the life the Joint Development Agreement discussed below. The Company recorded deferred revenue of $0 and $666,667 as of June 30, 2013 and September 30, 2012, respectively.
STOCK BASED COMPENSATION - The Company has share-based compensation plans under which employees, consultants, suppliers and directors may be granted restricted stock, as well as options to purchase shares of Company common stock at the fair market value at the time of grant. Stock-based compensation cost is measured by the Company at the grant date, based on the fair value of the award, over the requisite service period. For options issued to employees, the Company recognizes stock compensation costs utilizing the fair value methodology over the related period of benefit. Grants of stock options and stock to non-employees and other parties are accounted for in accordance with the ASC 505.
INCOME TAXES - Income tax benefit is based on reported loss before income taxes. Deferred income taxes reflect the effect of temporary differences between asset and liability amounts that are recognized for financial reporting purposes and the amounts that are recognized for income tax purposes. These deferred taxes are measured by applying currently enacted tax laws where that company operates out of. The Company recognizes refundable and deferred assets to the extent that management has determined their realization. As of June 30, 2013 and September 30, 2012, the Company had refundable tax assets related to TransTech of $30,045 and $29,316, respectively.
NET LOSS PER SHARE Under the provisions of ASC 260, Earnings Per Share, basic loss per common share is computed by dividing net loss available to common shareholders by the weighted average number of shares of common stock outstanding for the periods presented. Diluted net loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that would then share in the income of the Company, subject to anti-dilution limitations. The common stock equivalents have not been included as they are anti-dilutive. As of June 30, 2013, there were options outstanding for the purchase of 11,005,000 common shares, warrants for the purchase of 112,357,050 common shares, and an undetermined number shares of common stock related to convertible debt, which could potentially dilute future earnings per share. As of June 30, 2012, there were options outstanding for the purchase of 9,020,000 common shares, warrants for the purchase of 4,977,051 common shares, and an undetermined number shares of common stock related to convertible debt, which could potentially dilute future earnings per share.
DIVIDEND POLICY - The Company has never paid any cash dividends and intends, for the foreseeable future, to retain any future earnings for the development of our business. Our future dividend policy will be determined by the board of directors on the basis of various factors, including our results of operations, financial condition, capital requirements and investment opportunities.
USE OF ESTIMATES - The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
RECENT ACCOUNTING PRONOUNCEMENTS
A variety of proposed or otherwise potential accounting standards are currently under study by standard setting organizations and various regulatory agencies. Due to the tentative and preliminary nature of those proposed standards, management has not determined whether implementation of such proposed standards would be material to our consolidated financial statements. |
6. ACQUISITION OF TRANSTECH SYSTEMS, INC.
|
9 Months Ended |
---|---|
Jun. 30, 2013
|
|
Notes to Financial Statements | |
ACQUISITION OF TRANSTECH SYSTEMS, INC. | Our wholly owned subsidiary, TransTech Systems, is based in Aurora, Oregon, and was founded in 1994. TransTech provides value-added security and authentication solutions to corporate and government security and law enforcement markets throughout the United States. With recorded revenues of $7.6 million in 2012, TransTech has a respected national reputation for outstanding product knowledge, sales and service excellence.
The Company closed the acquisition of TransTech on June 8, 2010. The Company acquired its 100% interest in TransTech by issuing a Promissory Note to James Gingo, the President of TransTech, in the amount of $2,300,000, plus interest at the rate of three and one-half percent per annum from the date of the Note. The Note was secured by a security interest in the stock and assets of TransTech, and was payable over a period of three years. The final balance of $1,000,000 on the Note and accrued interest of $30,397 were paid to Mr. Gingo on June 12, 2013, to complete the purchase price for the TransTech stock.
On June 8, 2010 in connection with the acquisition of TransTech, the Company issued a total of 3,800,000 shares of restricted common stock of the Company to James Gingo, Jeff Kruse and Steve Waddle, executives of TransTech, and Paul Bonderson, a TransTech investor. The parties valued the shares in this transaction at $76,000 or $0.02 per share, the closing bid price during negotiations.
This acquisition was entered into to accelerate market entry and penetration through well-operated and positioned dealers of security and authentication systems, thus creating a natural distribution channel for products featuring the Companys proprietary ChromaID technology. |
4. DEVELOPMENT OF CHROMAID(TM) TECHNOLOGY
|
9 Months Ended |
---|---|
Jun. 30, 2013
|
|
Notes to Financial Statements | |
4. DEVELOPMENT OF CHROMAID(TM) TECHNOLOGY | The Companys ChromaID Technology
The Company has invented a way to project light at a material (solid surface, liquid, or gas) and measure the amount of light that is reflected back. The pattern of this reflected light is compared to other patterns the Company has captured and this allows the Company to identify, detect, or diagnose materials that cannot be identified by the human eye. The Company refers to this pattern of reflected light as a ChromaID. The Company designs ChromaID scanning devices made with electronic, optical, and software parts to produce and capture the light.
The Companys first product, the ChromaID F12 Lab Kit, scans and identifies solid surfaces. The Company is marketing this product to customers who are considering licensing the technology. Target markets include, but are not limited to, commercial paint manufacturers, pharmaceutical equipment manufacturers, process control companies, currency paper and ink manufacturers, security card, reader, and scanner manufacturers, food processing, and electronic gaming.
The Companys Patents
On August 9, 2011, the Company was issued US Patent No. 7,996,173 B2 entitled Method, Apparatus and Article to Facilitate Distributed Evaluation of Objects Using Electromagnetic Energy, by the United States Office of Patents and Trademarks. The patent expires August 24, 2029.
On December 13, 2011, the Company was issued US Patent No. 8,076,630 B2 entitled System and Method of Evaluating an Object Using Electromagnetic Energy by the United States Office of Patents and Trademarks. The patent expires November 7, 2028.
On December 20, 2011, the Company was issued US Patent No. 8,081,304 B2 entitled Method, Apparatus and Article to Facilitate Evaluation of Objects Using Electromagnetic Energy by the United States Office of Patents and Trademarks. The patent expires July 28, 2030.
On October 9, 2012, the Company was issued US Patent No. 8,285,510 B2 entitled Method, Apparatus, and Article to Facilitate Distributed Evaluation of Objects Using Electromagnetic Energy by the United States Office of Patents and Trademarks. The patent expires July 31, 2027.
On February 5, 2013, the Company was issued US Patent No. 8,368,878 B2 entitled Method, Apparatus and Article To Facilitate Evaluation of Objects Using Electromagnetic Energy by the United States Office of Patents and Trademarks. The patent expires July 31, 2027.
The Company is pursuing an aggressive patent strategy to expand our unique intellectual property in the United States and Japan and other countries. |
10. INTANGIBLE ASSETS (Details) (USD $)
|
Jun. 30, 2013
|
Sep. 30, 2012
|
---|---|---|
Less: accumulated amortization | $ (840,456) | $ (586,034) |
Intangible assets, net | 855,689 | 1,110,111 |
CustomerContractsMember
|
||
Intangible Assets Gross | 983,645 | 983,645 |
TechnologyMember
|
||
Intangible Assets Gross | $ 712,500 | $ 712,500 |
10. INTANGIBLE ASSETS (Tables)
|
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Notes to Financial Statements | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Intangible Assets | Intangible assets as of June 30, 2013 and September 30, 2012 consisted of the following:
|
18. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS (Tables)
|
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
|||||||||||||||||||||||||||||||||||||||||
Notes to Financial Statements | |||||||||||||||||||||||||||||||||||||||||
Schedule Of Future Minimum Lease Payments For Operating Leases | The aggregate future minimum lease payments under operating leases, to the extent the leases have early cancellation options and excluding escalation charges, are as follows:
|
7. ACCOUNTS RECEIVABLE/CUSTOMER CONCENTRATION (Details Narrative) (USD $)
|
Jun. 30, 2013
|
Sep. 30, 2012
|
Jun. 30, 2012
|
---|---|---|---|
Notes to Financial Statements | |||
Accounts receivable, net of allowance | $ 809,856 | $ 1,012,697 | $ 1,012,697 |
18. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS (Details) (USD $)
|
Jun. 30, 2013
|
---|---|
Notes to Financial Statements | |
2014 | $ 105,611 |
2015 | 65,292 |
2016 | 38,008 |
2017 | |
2018 | |
Beyond | |
Total | $ 208,911 |